![Karin Hehenberger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karin Hehenberger
Directeur/Membre du Conseil chez
DIAMYD MEDICAL AB
Fortune : 1 080 $ au 31/07/2026
Profil
Karin M.
Hehenberger was the founder of Lyfebulb LLC, founded in 2014, where the title held was Chief Executive Officer & Director.
Dr. Hehenberger is also the founder of Lyfebulb Holdings, Inc...
Current jobs include Independent Director at Diamyd Medical AB since 2021, Director at Amal Therapeutics SA, Director at Aadi Subsidiary, Inc., Director at Rolf Lufts Stiftelse Foer Diabetesforskning since 2004, Director at AnaCardio AB since 2022, and Chief Medical Officer at Diabetic Care Rx LLC.
Former jobs include Senior Director-Scientific Communications at Oldtech, Inc., Director at Lighthouse International, Independent Director at Whitehawk Therapeutics, Inc. from 2021 to 2025, Director at Newron Sweden AB, Partner & Investment Director at Scandinavian Life Science Ventures AB from 2005 to 2008, Director at Atlas Antibodies AB, Director at American Diabetes Association, VP-Metabolics Strategy & Business Development at Johnson & Johnson, Executive Vice President-Scientific Affairs at Fortress Biotech, Inc. in 2013, Consultant at McKinsey & Co., Inc., Senior Vice President-Strategic Alliances at JDRF International, Post-Doctoral Fellow at Joslin Diabetes Center, Inc., and SVP-Medical Affairs & Corporate Communications at Immune Pharmaceuticals, Inc. Education includes a doctorate from Karolinska Institutet.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/08/2025 | 10 000 ( 0,01 % ) | 1 080 $ | 31/07/2026 |
Postes actifs de Karin Hehenberger
| Sociétés | Poste | Début |
|---|---|---|
| DIAMYD MEDICAL AB | Directeur/Membre du Conseil | 28/04/2021 |
AnaCardio AB
 AnaCardio AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops novel drugs to treat heart failure | Directeur/Membre du Conseil | 01/09/2022 |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Directeur/Membre du Conseil | - |
Rolf Lufts Stiftelse Foer Diabetesforskning | Directeur/Membre du Conseil | 01/12/2004 |
Amal Therapeutics SA
 Amal Therapeutics SA BiotechnologyHealth Technology Operates a proprietary cell penetrating peptide platform which develops therapeutic vaccines in oncology | Directeur/Membre du Conseil | - |
Diabetic Care Rx LLC
 Diabetic Care Rx LLC Medical/Nursing ServicesHealth Services Provides nutritional therapy services to patients with end stage renal disease | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Karin Hehenberger
| Sociétés | Poste | Fin |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/06/2025 |
| FORTRESS BIOTECH, INC. | Directeur Technique/Scientifique/R&D | 05/11/2013 |
Lighthouse International
 Lighthouse International Personnel ServicesCommercial Services Provides rehabilitation, education, research and advocacy services | Directeur/Membre du Conseil | 18/09/2013 |
| ░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Karin Hehenberger
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
Fortress Biotech, Inc.
 Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lighthouse International
Lighthouse International Personnel ServicesCommercial Services Provides rehabilitation, education, research and advocacy services | Commercial Services |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic drugs for central nervous system disorders | Health Technology |
American Diabetes Association
 American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | Commercial Services |
Scandinavian Life Science Ventures AB
 Scandinavian Life Science Ventures AB Investment ManagersFinance SLS Invest is an active manager which provides financing for early, later, and growth-stage capital requirements, as well as providing management support. The firm targets companies operating in the health technology sector, and industries such as biotechnology and pharmaceuticals. It invests in young companies located in Northern Europe and the United States, and looks to take both minority and majority stake positions in its investments, as well as a seat on the board. | Finance |
JDRF International
 JDRF International Miscellaneous Commercial ServicesCommercial Services Performs research & development on diabetes | Commercial Services |
Atlas Antibodies AB
 Atlas Antibodies AB BiotechnologyHealth Technology Develops, produces and markets reagents for biomedical research | Health Technology |
Joslin Diabetes Center, Inc.
 Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for diabetes | Health Technology |
Diamyd Medical AB
 Diamyd Medical AB Pharmaceuticals: MajorHealth Technology Develops precision medicine drugs for type 1 diabetes and other forms of autoimmune diabetes | Health Technology |
Diabetic Care Rx LLC
Diabetic Care Rx LLC Medical/Nursing ServicesHealth Services Provides nutritional therapy services to patients with end stage renal disease | Health Services |
Immune Pharmaceuticals, Inc.
 Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
Amal Therapeutics SA
Amal Therapeutics SA BiotechnologyHealth Technology Operates a proprietary cell penetrating peptide platform which develops therapeutic vaccines in oncology | Health Technology |
Rolf Lufts Stiftelse Foer Diabetesforskning | |
Aadi Subsidiary, Inc.
Aadi Subsidiary, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Lyfebulb LLC
 Lyfebulb LLC Internet Software/ServicesTechnology Services Operates as an online digital platform for people living with chronic illnesses | Technology Services |
AnaCardio AB
AnaCardio AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops novel drugs to treat heart failure | Commercial Services |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
